Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,812 | -52,171 | -33,851 | -17,360 | -50,422 |
| Depreciation Amortization | 721 | 430 | 186 | 55 | -342 |
| Other Working Capital | 376 | -1,990 | 797 | 2,882 | -2,133 |
| Other Operating Activity | 10,688 | 7,642 | 4,783 | 2,193 | 6,516 |
| Operating Cash Flow | $-62,027 | $-46,089 | $-28,085 | $-12,230 | $-46,381 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 403 | 9,278 | 34,013 | 16,399 | 42,159 |
| PPE Investments | -186 | -169 | -72 | -60 | -492 |
| Investing Cash Flow | $217 | $9,109 | $33,941 | $16,339 | $41,667 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114,571 | 114,474 | 114,632 | 6,482 | 126 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -59 |
| Financing Cash Flow | $114,571 | $114,474 | $114,632 | $6,482 | $67 |
| Beginning Cash Position | 40,826 | 40,826 | 40,826 | 40,826 | 45,473 |
| End Cash Position | 93,587 | 118,320 | 161,314 | 51,417 | 40,826 |
| Net Cash Flow | $52,761 | $77,494 | $120,488 | $10,591 | $-4,647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,027 | -46,089 | -28,085 | -12,230 | -46,381 |
| Capital Expenditure | -186 | -169 | -72 | -60 | -492 |
| Free Cash Flow | -62,213 | -46,258 | -28,157 | -12,290 | -46,873 |